XML 78 R35.htm IDEA: XBRL DOCUMENT v3.19.3
Stockholder's Equity (Tables)
12 Months Ended
Jul. 31, 2019
Equity [Abstract]  
Schedule of stock options exercised utilizing a cashless exercise
The exercised stock options, utilizing a cashless exercise, are summarized in the following table:
Period
 
Options Exercised
 
Weighted Average Exercise Price
 
Shares Net Settled for Exercise
 
Shares Withheld for Taxes (1)
 
Net Shares to Employees
 
Weighted Average Share Price for Withholding
 
Employee Stock Based Tax Withholding (in 000s)
FY 2017—Q1
 
18,000,000

 
$
7.70

 
5,408,972

 
5,255,322

 
7,335,706

 
$
25.62

 
$
134,615

FY 2018—Q2
 
80,000

 
6.54

 
11,996

 

 
68,004

 
43.60

 

FY 2019—Q3
 
3,000,000

 
17.81

 
945,162

 
806,039

 
1,248,799

 
56.53

 
45,565

(1)
Shares withheld for taxes are treated as a repurchase of shares for accounting purposes but do not count against the Company’s stock repurchase program.
Schedule of share-based compensation expense
The following table details stock-based compensation recognized by the Company for stock options and restricted stock awards:
 
 
Year Ended July 31,
(In thousands)
 
2019
 
2018
 
2017
General and administrative
 
$
18,254

 
$
19,351

 
$
17,622

Yard operations
 
5,191

 
3,870

 
3,286

Total stock-based compensation
 
$
23,445

 
$
23,221

 
$
20,908


Schedule of non-vested shares
A summary of the status of the Company’s non-vested shares from stock option awards and its activity during the year ended July 31, 2019 was as follows:
(In thousands, except per share amounts)
 
Number of
Shares
 
Weighted
Average Grant-
date Fair Value
Non-vested shares at July 31, 2018
 
5,516

 
$
6.96

Grants of non-vested shares
 
1,950

 
15.47

Vested
 
(3,125
)
 
6.81

Forfeitures or expirations
 
(132
)
 
6.18

Non-vested shares at July 31, 2019
 
4,209

 
$
11.05


Schedule of option activity
The following is a summary of activity for the Company’s stock options for the year ended July 31, 2019:
(In thousands, except per share and term data)
 
Shares
 
Weighted
Average
Exercise Price
 
Weighted Average
Remaining
Contractual Term
(In years)
 
Aggregate
Intrinsic
Value
Outstanding as of July 31, 2018
 
17,797

 
$
20.29

 
6.19
 
$
660,268

Grants of options
 
1,950

 
57.91

 
 
 
 
Exercises
 
(5,063
)
 
17.35

 
 
 
 
Forfeitures or expirations
 
(132
)
 
27.29

 
 
 
 
Outstanding as of July 31, 2019
 
14,552

 
$
26.29

 
6.04
 
$
745,592

 
 
 
 
 
 
 
 
 
Exercisable as of July 31, 2019
 
10,343

 
$
19.77

 
5.13
 
$
597,352

 
 
 
 
 
 
 
 
 
Vested and expected to vest as of July 31, 2019
 
14,024

 
$
25.68

 
5.99
 
$
727,091


Schedule of restricted stock activity The following is a summary of activity for the Company’s restricted stock for the for the year ended July 31, 2019:
(In thousands, except per share data)
 
Restricted Shares
 
Weighted Average Grant Date Fair Value
Outstanding as of July 31, 2018
 
28

 
$
36.12

Grants of restricted stock
 
162

 
55.57

Vested restricted stock
 
(52
)
 
42.70

Forfeited restricted stock
 
(4
)
 
49.54

Outstanding as of July 31, 2019
 
134

 
$
56.62


Schedule of stock options outstanding and exercisable
The following table summarizes stock options outstanding and exercisable as of July 31, 2019:
(In thousands, except per share amounts)
 
Options Outstanding
 
Options Exercisable
Range of Exercise Prices
 
Number
 
Weighted
Average
Remaining
Contractual
Life
 
Weighted
Average
Exercise
Price
 
Number
 
Weighted
Average
Exercise
Price
$8.28–$17.64
 
891

 
2.60
 
$
11.94

 
871

 
$
11.82

$17.73–$17.81
 
6,110

 
4.87
 
17.78

 
5,592

 
17.79

$18.06–$34.78
 
4,208

 
6.23
 
23.16

 
3,289

 
21.52

$36.32–$77.51
 
3,343

 
8.84
 
49.60

 
591

 
40.57

Outstanding as of July 31, 2019
 
14,552

 
6.04
 
$
26.29

 
10,343

 
$
19.77